Karyopharm Therapeutics (KPTI) PT Lowered to $15 at Baird
Baird analyst Michael Ulz lowered ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)